CN113730376A - Thiamine nitrate sustained-release microcapsule and preparation method thereof - Google Patents

Thiamine nitrate sustained-release microcapsule and preparation method thereof Download PDF

Info

Publication number
CN113730376A
CN113730376A CN202111093268.0A CN202111093268A CN113730376A CN 113730376 A CN113730376 A CN 113730376A CN 202111093268 A CN202111093268 A CN 202111093268A CN 113730376 A CN113730376 A CN 113730376A
Authority
CN
China
Prior art keywords
thiamine nitrate
coconut shell
release
wall material
sustained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111093268.0A
Other languages
Chinese (zh)
Other versions
CN113730376B (en
Inventor
罗浩
付林
詹顺昌
魏旭丽
胡惠珊
王霜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUAZHONG PHARMACEUTICAL CO Ltd
Original Assignee
HUAZHONG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUAZHONG PHARMACEUTICAL CO Ltd filed Critical HUAZHONG PHARMACEUTICAL CO Ltd
Priority to CN202111093268.0A priority Critical patent/CN113730376B/en
Publication of CN113730376A publication Critical patent/CN113730376A/en
Application granted granted Critical
Publication of CN113730376B publication Critical patent/CN113730376B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5063Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a thiamine nitrate slow-release microcapsule, which comprises a wall material and a core material, wherein the wall material comprises a modified coconut shell and polyethyleneimine, and the core material is thiamine nitrate; the core material is wrapped in the wall material. According to the invention, the waste coconut shells are subjected to high-temperature carbonization, plant hydrolase hydrolysis and other treatments to obtain modified coconut shells, and then are subjected to crosslinking reaction with polyethyleneimine to obtain the wall material, so that the slow release effect of the thiamine nitrate slow-release microcapsule is greatly enhanced through the synergistic effect of the modified coconut shells and the polyethyleneimine, and meanwhile, the waste coconut shells are utilized, so that the waste is changed into valuable, the resources are saved, and the pressure of environmental protection is reduced; the polyethyleneimine contains a large amount of primary amino groups and secondary amino groups with positive charges, so that the prepared thiamine nitrate slow-release microcapsules have uniform dispersion and are not easy to adhere due to the action of electrostatic repulsion between the surfaces of the microcapsules.

Description

Thiamine nitrate sustained-release microcapsule and preparation method thereof
Technical Field
The invention belongs to the technical field of preparation of medicinal preparations, and particularly relates to a thiamine nitrate sustained-release microcapsule and a preparation method thereof.
Background
Vitamin B1 is a compound formed by bonding a pyrimidine ring and a thiazole ring, and is named thiamine because it contains sulfur and amine in the molecule. The vitamin B1 for general medical use is hydrochloride (thiamine hydrochloride) of chemically synthesized vitamin B1, and the thiamine nitrate (thiamine nitrate) is nitrate of vitamin B1, and is commonly used as a nutritional supplement, a food additive, a compound vitamin preparation and the like. Because it is more stable than thiamine hydrochloride in water, thiamine nitrate is more suitable for preparing powder and tablet medicines, and thiamine nitrate is white or off-white powder as a raw material and has peculiar smell; the product is slightly soluble in water (1g/35ml) and slightly soluble in ethanol, methanol or chloroform. As a feed additive, the vitamin B1 has important functions on maintaining normal nerve conduction and normal activities of the heart and the digestive system, and is easy to generate symptoms such as carbohydrate metabolism disorder, anorexia and the like when the livestock and poultry are deficient; in the field of medicine, the medicine is applicable to vitamin B1 deficiency, has the functions of maintaining normal glycometabolism and nerve conduction, and is also used for adjuvant therapy of dyspepsia, neuritis and the like.
The nitrate of vitamin B1 (thiamine nitrate) belongs to BCS classification III, dissolves rapidly in vitro, and MHRA public review report of British marketed preparation (trade name: Tyvera) indicates that thiamine is rapidly absorbed in human body, supporting biological exemption. Chinese patent document CN 102988300A discloses a thiamine nitrate particle and a preparation method thereof, specifically, firstly, 850 weight parts of thiamine nitrate powder is placed in a wet granulator, 50 to 200 weight parts of wetting agent is added, and the mixture is stirred to form pasty liquid; then adding 1-50 parts by weight of adhesive into the pasty liquid, and uniformly stirring to form wet granules; finally, drying the prepared wet granules by a fluidized bed, and screening the granules by a vibrating screen to obtain thiamine nitrate, wherein the preparation method is simple and convenient in process, low in cost, controllable in quality and suitable for industrialization; the prepared thiamine nitrate particles have the characteristic of good fluidity, the problem of poor fluidity during premixing is solved, the dust yield is reduced, the premixing time is shortened, and the labor efficiency is improved; chinese patent document CN 111481516A discloses a pharmaceutical composition containing vitamin B1 and its preparation method, wherein the pharmaceutical composition containing vitamin B1 comprises the following components by weight: 8 percent of vitamin B1 raw material, 70 to 85 percent of filling agent, 2 to 5 percent of disintegrating agent, 0.5 percent of flavoring agent, 0.3 to 0.5 percent of lubricant and 0.3 to 0.5 percent of glidant. The preparation method adopts direct compression process to tablet the pharmaceutical composition, and the mode is stable and easy to control; meanwhile, the process is simple and convenient to operate.
In the above patent documents, an additive is added to thiamine nitrate, and the mixture is granulated or tableted. However, the granular or tablet thiamine nitrate is released rapidly in vivo, and the aim of continuous administration and continuous treatment is not achieved. Therefore, it is necessary to provide thiamine nitrate sustained-release microcapsules which have a good sustained-release effect and are stable in sustained release.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provides a thiamine nitrate slow-release microcapsule and a preparation method thereof. After entering the body, the thiamine nitrate sustained-release microcapsule prepared by the invention can be slowly and stably released, thereby achieving the purposes of continuous administration and continuous treatment and improving the curative effect of thiamine nitrate medicines to the greatest extent.
The invention aims to provide a thiamine nitrate slow-release microcapsule.
The thiamine nitrate slow-release microcapsule comprises a wall material and a core material, wherein the wall material comprises a modified coconut shell and polyethyleneimine, and the core material is thiamine nitrate; the core material is wrapped in the wall material.
Further, the mass ratio of the core material to the wall material is 1: (5-15); the mass ratio of the modified coconut shells to the polyethyleneimine is (1-5): 1.
further, the preparation method of the modified coconut shell comprises the following steps: the preparation method comprises the steps of cleaning coconut shells, crushing, sieving, carbonizing in a vacuum environment to obtain coconut shell carbon ash, dissolving the coconut shell carbon ash in water to obtain a coconut shell carbon ash aqueous solution, and finally adding plant hydrolase powder into the coconut shell carbon ash aqueous solution to perform enzymolysis reaction to obtain the modified coconut shell solution.
Furthermore, the carbonization temperature is 250-350 ℃, and the carbonization time is 1.5-2.5 h.
Furthermore, the addition amount of the plant hydrolase powder is 0.05-0.1% (W/V), the temperature of the enzymolysis reaction is 25-40 ℃, and the time is 1-2 hours.
The thiamine nitrate slow-release microcapsule comprises a wall material and a core material, wherein the wall material comprises a modified coconut shell and polyethyleneimine, and the core material is thiamine nitrate; the coconut shells are rich in lignin, cellulose and pentosan, after high-temperature carbonization and plant hydrolase hydrolysis, most of the lignin, cellulose and pentosan are degraded into small molecular substances which contain a large amount of hydroxyl groups with negative charges, and because polyethyleneimine is a high-molecular reticular polymer which contains a large amount of primary amino groups and secondary amino groups with positive charges, when the two are subjected to crosslinking reaction, the modified coconut shell small molecules are filled in gaps of the polyethyleneimine, so that the strength of the wall material is increased, the pores are reduced, and the slow release effect of the wall material is enhanced; the slow release effect of the thiamine nitrate slow release microcapsule is greatly enhanced by the synergistic effect of the modified coconut shell and the polyethyleneimine; in addition, because the polyethyleneimine contains a large number of primary amino groups and secondary amino groups with positive charges, the prepared thiamine nitrate slow-release microcapsules are uniformly dispersed and are not easy to adhere due to the action of electrostatic repulsion between the surfaces of the microcapsules.
The invention also aims to provide a preparation method of the thiamine nitrate sustained-release microcapsule.
The preparation method of the thiamine nitrate slow-release microcapsule comprises the following steps:
s1, preparation of wall materials: cleaning coconut shells, crushing, sieving, and carbonizing in a vacuum environment at the temperature of 250-350 ℃ for 1.5-2.5 h to obtain coconut shell carbon ash, dissolving the coconut shell carbon ash in water to obtain a coconut shell carbon ash aqueous solution, adding plant hydrolase powder into the coconut shell carbon ash aqueous solution for enzymolysis to obtain a modified coconut shell solution, and finally adding polyethyleneimine into the modified coconut shell solution to obtain a wall material mixed solution, wherein the mass ratio of the modified coconut shells to the polyethyleneimine in the wall material mixed solution is (1-5): 1;
s2, preparation of a core material: dissolving thiamine nitrate in an organic solvent, and stirring and mixing uniformly to obtain a thiamine nitrate solution;
s3, preparing thiamine nitrate sustained-release microcapsules: and (4) slowly dropwise adding the thiamine nitrate solution prepared in the step (S2) into the wall material mixed solution prepared in the step (S1), uniformly mixing, homogenizing under high pressure, and freeze-drying to finally prepare the thiamine nitrate slow-release microcapsule.
Further, in step S2, the organic solvent is one or more of ethanol, methanol, or chloroform.
Further, the mass concentration of the thiamine nitrate solution is 0.5-1%.
Further, in step S3, the conditions of the high-pressure homogenization are as follows: homogenizing for 6-8 times at 25-35 deg.C and 140-160 par.
Further, in step S3, the freeze-drying conditions are as follows: the vacuum drying temperature is controlled to be-5 ℃, the drying time is 6-8 hours, and the vacuum degree in the vacuum freeze drying process is 3-4 Pa.
Compared with the prior art, the invention has the following advantages:
1) according to the invention, the waste coconut shells are subjected to high-temperature carbonization, plant hydrolase hydrolysis and other treatments to obtain modified coconut shells, and then are subjected to crosslinking reaction with polyethyleneimine to obtain the wall material, so that the slow release effect of the thiamine nitrate slow-release microcapsule is greatly enhanced through the synergistic effect of the modified coconut shells and the polyethyleneimine, and meanwhile, the waste coconut shells are utilized, so that the waste is changed into valuable, the resources are saved, and the pressure of environmental protection is reduced;
2) the polyethyleneimine contains a large amount of primary amino groups and secondary amino groups with positive charges, so that the prepared thiamine nitrate slow-release microcapsules have uniform dispersion and are not easy to adhere due to the action of electrostatic repulsion between the surfaces of the microcapsules.
Drawings
In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings needed to be used in the description of the embodiments are briefly introduced below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and it is obvious for those skilled in the art to obtain other drawings based on these drawings without creative efforts.
FIG. 1 is a flow chart of the preparation of thiamine nitrate sustained-release microcapsules of the present invention.
Detailed Description
The technical solution in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention. It is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments, and all other embodiments obtained by those skilled in the art without any inventive work are within the scope of the present invention.
The reagents and equipment used in the present invention are commercially available unless otherwise specified.
Example 1
The preparation method of the thiamine nitrate slow-release microcapsule comprises the following steps:
s1, preparation of wall materials: cleaning coconut shells, crushing and sieving the coconut shells, carbonizing the coconut shells in a vacuum environment to obtain coconut shell carbon ash, dissolving the coconut shell carbon ash in water to obtain a coconut shell carbon ash aqueous solution, adding plant hydrolase powder into the coconut shell carbon ash aqueous solution to perform an enzymolysis reaction, wherein the addition amount of the plant hydrolase powder is 0.05% (W/V), the temperature of the enzymolysis reaction is 25 ℃, the time is 1h, a modified coconut shell solution is prepared, and finally polyethyleneimine is added into the modified coconut shell solution to obtain a wall material mixed solution, wherein the mass ratio of the modified coconut shells to the polyethyleneimine in the wall material mixed solution is 1: 1;
s2, preparation of a core material: dissolving thiamine nitrate in ethanol, and stirring and mixing uniformly to obtain a thiamine nitrate solution, wherein the mass concentration of the thiamine nitrate solution is 0.5%;
s3, preparing thiamine nitrate sustained-release microcapsules: slowly and dropwise adding the thiamine nitrate solution prepared in the step S2 into the wall material mixed solution prepared in the step S1, uniformly mixing, and then carrying out high-pressure homogenization and freeze drying, wherein the high-pressure homogenization conditions are as follows: homogenizing at 25 deg.C and 140par for 6 times; the conditions for the freeze-drying were as follows: controlling the vacuum drying temperature at-5 ℃, the drying time at 6h, and the vacuum degree in the vacuum freeze drying process at 3 Pa; finally, the thiamine nitrate slow-release microcapsule is prepared.
Example 2
The preparation method of the thiamine nitrate slow-release microcapsule comprises the following steps:
s1, preparation of wall materials: cleaning coconut shells, crushing and sieving the coconut shells, carbonizing the coconut shells in a vacuum environment to obtain coconut shell carbon ash, dissolving the coconut shell carbon ash in water to obtain a coconut shell carbon ash aqueous solution, adding plant hydrolase powder into the coconut shell carbon ash aqueous solution to perform an enzymolysis reaction, wherein the addition amount of the plant hydrolase powder is 0.08% (W/V), the temperature of the enzymolysis reaction is 35 ℃, the time is 1.5 hours, a modified coconut shell solution is prepared, and finally polyethyleneimine is added into the modified coconut shell solution to obtain a wall material mixed solution, wherein the mass ratio of the modified coconut shells to the polyethyleneimine in the wall material mixed solution is 3: 1;
s2, preparation of a core material: dissolving thiamine nitrate in a mixed solution of methanol and chloroform, and stirring and mixing uniformly to obtain a thiamine nitrate solution, wherein the mass concentration of the thiamine nitrate solution is 0.8%;
s3, preparing thiamine nitrate sustained-release microcapsules: slowly and dropwise adding the thiamine nitrate solution prepared in the step S2 into the wall material mixed solution prepared in the step S1, uniformly mixing, and then carrying out high-pressure homogenization and freeze drying, wherein the high-pressure homogenization conditions are as follows: homogenizing at 30 deg.C and 150par for 7 times; the conditions for the freeze-drying were as follows: controlling the vacuum drying temperature at 0 ℃, the drying time at 7h, and the vacuum degree in the vacuum freeze drying process at 3.5 Pa; finally, the thiamine nitrate slow-release microcapsule is prepared.
Example 3
The preparation method of the thiamine nitrate slow-release microcapsule comprises the following steps:
s1, preparation of wall materials: cleaning coconut shells, crushing and sieving the coconut shells, carbonizing the coconut shells in a vacuum environment to obtain coconut shell carbon ash, dissolving the coconut shell carbon ash in water to obtain a coconut shell carbon ash aqueous solution, adding plant hydrolase powder into the coconut shell carbon ash aqueous solution to perform an enzymolysis reaction, wherein the addition amount of the plant hydrolase powder is 0.1% (W/V), the temperature of the enzymolysis reaction is 40 ℃, the time is 2 hours, a modified coconut shell solution is prepared, and finally polyethyleneimine is added into the modified coconut shell solution to obtain a wall material mixed solution, wherein the mass ratio of the modified coconut shells to the polyethyleneimine in the wall material mixed solution is 5: 1;
s2, preparation of a core material: dissolving thiamine nitrate in methanol, and stirring and mixing uniformly to obtain a thiamine nitrate solution, wherein the mass concentration of the thiamine nitrate solution is 1%;
s3, preparing thiamine nitrate sustained-release microcapsules: slowly and dropwise adding the thiamine nitrate solution prepared in the step S2 into the wall material mixed solution prepared in the step S1, uniformly mixing, and then carrying out high-pressure homogenization and freeze drying, wherein the high-pressure homogenization conditions are as follows: homogenizing at 35 deg.C and 160par for 8 times; the conditions for the freeze-drying were as follows: controlling the vacuum drying temperature at 5 ℃, the drying time at 8h, and the vacuum degree in the vacuum freeze drying process at 4 Pa; finally, the thiamine nitrate slow-release microcapsule is prepared.
Comparative example 1
The preparation method of the thiamine nitrate slow-release microcapsule is basically the same as that in example 2, except that modified coconut shells are not added in the preparation of the wall materials.
Comparative example 2
The preparation method of the thiamine nitrate slow-release microcapsule is basically the same as that in the example 2, except that the modified coconut shells are not subjected to a vacuum carbonization step in the preparation of the wall material.
Comparative example 3
The preparation method of the thiamine nitrate slow-release microcapsule is basically the same as that in the example 2, except that the modified coconut shells are not subjected to the enzymolysis step of plant hydrolase powder in the preparation of the wall material.
Comparative example 4
The preparation method of the thiamine nitrate sustained-release microcapsule is basically the same as that of the embodiment 2, except that polyethyleneimine is not added in the preparation of the wall material.
Example 4 Performance testing of thiamine nitrate sustained Release microcapsules
Some of the thiamine nitrate sustained-release microcapsules prepared in examples 1 to 3 and comparative examples 1 to 4 were subjected to a test for cumulative release amount, and the other part was subjected to an observation test for storage time (normal temperature, light-shielding treatment), and the results are shown in table 1:
TABLE 1 thiamine nitrate sustained-release microcapsule Performance test results
Figure BDA0003268130710000081
The results in the table show that the thiamine nitrate sustained-release microcapsules prepared in the embodiments 1 to 3 release thiamine nitrate slowly within 2 hours, the release amount is about 15%, and the cumulative release amount within 8 hours is less than 80%, and the results show that the thiamine nitrate sustained-release microcapsules prepared in the invention can release thiamine nitrate slowly and stably, achieve the purposes of continuous administration and continuous treatment, and improve the curative effect of thiamine nitrate medicines to the greatest extent;
the difference between the comparative examples 1 and 4 and the example 2 is that only one of the modified coconut shell and the polyethyleneimine is added, and as a result, the cumulative release amount of thiamine nitrate in the comparative examples 1 and 4 is faster, and the slow release effect is poorer, and the slow release effect of the example 2 is good because when the two carry out crosslinking reaction, the modified coconut shell micromolecules are filled in the gaps of the polyethyleneimine, so that the strength of the wall material is increased on one hand, and in addition, the pores are reduced, and the slow release effect of the wall material is enhanced; the slow release effect of the thiamine nitrate slow release microcapsule is greatly enhanced by the synergistic effect of the modified coconut shell and the polyethyleneimine;
the difference between the comparative examples 2 and 3 and the example 2 lies in that the modified coconut shell in the preparation of the wall material only has one of the vacuum carbonization step and the enzymolysis step of the plant hydrolase powder, and as a result, the cumulative release amount of thiamine nitrate in the comparative examples 2 and 3 is faster, and the slow release effect is poorer, and the slow release effect of the example 2 is good because the vacuum carbonization step in the preparation of the modified coconut shell and the enzymolysis step of the plant hydrolase powder are synergistic, so that the modified coconut shell is degraded into hydroxyl-containing micromolecule substances, and the reaction with polyethyleneimine is facilitated.
In conclusion, the invention greatly enhances the slow release effect of the thiamine nitrate slow release microcapsule by the synergistic effect of the modified coconut shell and the polyethyleneimine, and simultaneously utilizes the waste coconut shell, thereby changing waste into valuable, saving resources and reducing the pressure of environmental protection.
Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art will understand that: any person skilled in the art can modify or easily conceive the technical solutions described in the foregoing embodiments or equivalent substitutes for some technical features within the technical scope of the present disclosure; such modifications, changes or substitutions do not depart from the spirit and scope of the embodiments of the present invention, and they should be construed as being included therein.

Claims (10)

1. The thiamine nitrate slow-release microcapsule is characterized by comprising a wall material and a core material, wherein the wall material comprises a modified coconut shell and polyethyleneimine, and the core material is thiamine nitrate; the core material is wrapped in the wall material.
2. The thiamine nitrate sustained-release microcapsule according to claim 1, wherein the mass ratio of the core material to the wall material is 1: (5-15); the mass ratio of the modified coconut shells to the polyethyleneimine is (1-5): 1.
3. the thiamine nitrate sustained-release microcapsule according to claim 1, wherein the modified coconut shell is prepared by the following method: the preparation method comprises the steps of cleaning coconut shells, crushing, sieving, carbonizing in a vacuum environment to obtain coconut shell carbon ash, dissolving the coconut shell carbon ash in water to obtain a coconut shell carbon ash aqueous solution, and finally adding plant hydrolase powder into the coconut shell carbon ash aqueous solution to perform enzymolysis reaction to obtain the modified coconut shell solution.
4. The thiamine nitrate sustained-release microcapsule according to claim 3, wherein the carbonization temperature is 250-350 ℃ and the carbonization time is 1.5-2.5 h.
5. The thiamine nitrate sustained-release microcapsule according to claim 3, wherein the addition amount of the plant hydrolase powder is 0.05-0.1% (W/V), the temperature of the enzymolysis reaction is 25-40 ℃, and the time is 1-2 h.
6. The preparation method of thiamine nitrate sustained-release microcapsules according to any one of claims 1 to 5, characterized by comprising the steps of:
s1, preparation of wall materials: cleaning coconut shells, crushing, sieving, carbonizing in a vacuum environment to obtain coconut shell carbon ash, dissolving the coconut shell carbon ash in water to obtain a coconut shell carbon ash aqueous solution, adding plant hydrolase powder into the coconut shell carbon ash aqueous solution for an enzymolysis reaction to obtain a modified coconut shell solution, and finally adding polyethyleneimine into the modified coconut shell solution to obtain a wall material mixed solution, wherein the mass ratio of the modified coconut shells to the polyethyleneimine in the wall material mixed solution is (1-5): 1;
s2, preparation of a core material: dissolving thiamine nitrate in an organic solvent, and stirring and mixing uniformly to obtain a thiamine nitrate solution;
s3, preparing thiamine nitrate sustained-release microcapsules: and (4) slowly dropwise adding the thiamine nitrate solution prepared in the step (S2) into the wall material mixed solution prepared in the step (S1), uniformly mixing, homogenizing under high pressure, and freeze-drying to finally prepare the thiamine nitrate slow-release microcapsule.
7. The method for preparing thiamine nitrate sustained-release microcapsules according to claim 6, wherein in step S2, the organic solvent is one or more of ethanol, methanol or chloroform.
8. The preparation method of thiamine nitrate sustained-release microcapsules according to claim 7, wherein the mass concentration of the thiamine nitrate solution is 0.5-1%.
9. The method for preparing thiamine nitrate sustained-release microcapsules according to claim 6, wherein in step S3, the conditions of high-pressure homogenization are as follows: homogenizing for 6-8 times at 25-35 deg.C and 140-160 par.
10. The method for preparing thiamine nitrate sustained-release microcapsules according to claim 6, wherein in step S3, the conditions of freeze-drying are as follows: the vacuum drying temperature is controlled to be-5 ℃, the drying time is 6-8 hours, and the vacuum degree in the vacuum freeze drying process is 3-4 Pa.
CN202111093268.0A 2021-09-17 2021-09-17 Thiamine nitrate slow-release microcapsule and preparation method thereof Active CN113730376B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111093268.0A CN113730376B (en) 2021-09-17 2021-09-17 Thiamine nitrate slow-release microcapsule and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111093268.0A CN113730376B (en) 2021-09-17 2021-09-17 Thiamine nitrate slow-release microcapsule and preparation method thereof

Publications (2)

Publication Number Publication Date
CN113730376A true CN113730376A (en) 2021-12-03
CN113730376B CN113730376B (en) 2023-10-10

Family

ID=78739651

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111093268.0A Active CN113730376B (en) 2021-09-17 2021-09-17 Thiamine nitrate slow-release microcapsule and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113730376B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007091716A (en) * 2005-08-29 2007-04-12 Kuraray Co Ltd Drug-sustained releasing fine particle in water and method for producing the same
CN102106480A (en) * 2011-01-26 2011-06-29 广东省农业科学院畜牧研究所 B-complex crystal vitamin microcapsule and method for preparing microcapsules by utilizing spray drying method
CN107500292A (en) * 2017-09-25 2017-12-22 江苏苏利精细化工股份有限公司 A kind of method that graphene oxide is modified cocoanut active charcoal
CN108049191A (en) * 2017-12-12 2018-05-18 芜湖环瑞汽车内饰件有限公司 A kind of preparation method of automobile cushion microcapsule aromatic type coconut husk composite material
CN109180335A (en) * 2018-09-30 2019-01-11 芜湖县花桥镇恒乐水果种植专业合作社 A kind of grape slow-release compound fertilizer coconut shell flour sustained release agent preparation method
CN113208115A (en) * 2021-03-18 2021-08-06 南昌大学 Probiotic microcapsule and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007091716A (en) * 2005-08-29 2007-04-12 Kuraray Co Ltd Drug-sustained releasing fine particle in water and method for producing the same
CN102106480A (en) * 2011-01-26 2011-06-29 广东省农业科学院畜牧研究所 B-complex crystal vitamin microcapsule and method for preparing microcapsules by utilizing spray drying method
CN107500292A (en) * 2017-09-25 2017-12-22 江苏苏利精细化工股份有限公司 A kind of method that graphene oxide is modified cocoanut active charcoal
CN108049191A (en) * 2017-12-12 2018-05-18 芜湖环瑞汽车内饰件有限公司 A kind of preparation method of automobile cushion microcapsule aromatic type coconut husk composite material
CN109180335A (en) * 2018-09-30 2019-01-11 芜湖县花桥镇恒乐水果种植专业合作社 A kind of grape slow-release compound fertilizer coconut shell flour sustained release agent preparation method
CN113208115A (en) * 2021-03-18 2021-08-06 南昌大学 Probiotic microcapsule and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
周明松等: "静电自组装法制备阿维菌素微胶囊", vol. 34, no. 5, pages 519 - 524 *

Also Published As

Publication number Publication date
CN113730376B (en) 2023-10-10

Similar Documents

Publication Publication Date Title
Briššová et al. Control and measurement of permeability for design of microcapsule cell delivery system
CN101862443B (en) Preparation method of enramycin premix
WO2020113812A1 (en) Nadh-containing biological high-molecular-weight nanosphere, preparation method for same, and applications thereof
CN101869188B (en) Preparation method of nosiheptide premix
CN109364091A (en) Boiomacromolecule nanosphere containing NMN and the preparation method and application thereof
CN102813629A (en) Preparation method of tartaric acid valnemulin premixing agent
CN113730376A (en) Thiamine nitrate sustained-release microcapsule and preparation method thereof
CN1695589A (en) Method for preparing additive of stable micronized medication
CN101390840B (en) Production method of high-assay calcium ascorbate granules capable of directly being compressed
CN108543060B (en) A method of improving enramycin premix stability
CN106265702A (en) Acarbose medicine composition and preparation method thereof
CN103735544B (en) A kind of preparation technology of vildagliptin/metformin hydrochloride compound preparation
CN116063218A (en) Preparation method of monodispersity glimepiride spherical particles
CN115558151A (en) Aerogel taking mung bean protein and burdock nanocellulose as template for synergistically stabilizing foam
CN108066300A (en) A kind of glipizide tablet and preparation method thereof
CN114288255A (en) High-efficiency lecithin tablet and preparation method thereof
CN103110515A (en) Glucosamine potassium sulfate particle production method
CN106361708A (en) High-density micropill core and preparation method thereof
CN107397729A (en) A kind of preparation technology of blonanserin piece
CN1660057A (en) Solid dispersion and preoral combination of glibenclamide and preparation method
CN1781486A (en) Composite amino acid and vitamine capsule preparation and its preparing method
CN115381834B (en) Ticagrelor slow-release solid composition and capsule preparation containing same
CN112868934B (en) Nano montmorillonite meat rabbit feed additive compound for detoxification and diarrhea prevention
CN107669652A (en) A kind of preparation method for extracting species high-viscosity material particle
CN113425699A (en) Ursodeoxycholic acid capsule and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant